SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.
Source: news-medical.net
📰 Board Program At Harvard News
Board Program At Harvard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Board Program At Harvard. Real-time updates on events, politics, business and more.